Clot Removal Dramatically Improves Stroke Outcomes
By HospiMedica International staff writers Posted on 26 Apr 2015 |
Removing obstructing blood clots can significantly improve outcomes for people who suffer acute ischemic stroke, according to a new study.
Researchers at the UCLA Stroke Center (Los Angeles, CA, USA), University Hospital Essen (Germany), and 37 other institutions randomly assigned 196 eligible patients with stroke who were receiving or had received intravenous tissue plasminogen activator (t-PA) to continue with t-PA alone (control group, 98 patients) or to undergo endovascular thrombectomy with a stent retriever within six hours after symptom onset (intervention group, 96 patients). The primary outcome was the severity of global disability at 90 days on the modified Rankin scale.
The study, which was stopped early due to efficacy, showed that in the intervention group the rate of substantial reperfusion at the end of the procedure was 88%, compared to 25%–30% in the control group. Thrombectomy with the stent retriever plus intravenous t-PA also reduced disability at 90 days over the entire range of scores on the modified Rankin scale. Functional independence was higher in the intervention group (60%) than in the control group (35%). There were no significant differences in mortality or symptomatic intracranial hemorrhage. The study was published on April 17, 2015, in the New England Journal of Medicine (NEJM).
“We are very happy to see this decade-long research program result in an important advance for stroke patients. These findings are a paradigm shift — a new era in stroke care — and we are ecstatic,” said global lead author Prof. Jeffrey Saver, MD, director of the UCLA Stroke Center. “We will be able to treat many more patients, who will have much better outcomes. This is a once-in-a-generation advance in acute stroke care.”
“While this won’t help all stroke patients, the ones it will help have the most disabling strokes,” said study coauthor Sidney Starkman, MD, co-director of the UCLA Stroke Center. “Right now, they get t-PA and it helps a third of them, but the other two-thirds end up dependent on others for help or they die.”
For the study, the researchers used the Covidien (Dublin, Ireland) Solitaire FR revascularization device, a mechanical catheter-based thrombectomy system that combines the ability to restore blood flow, administer medical therapy, and retrieve clot in patients experiencing acute ischemic stroke.
Related Links:
UCLA Stroke Center
University Hospital Essen
Covidien
Researchers at the UCLA Stroke Center (Los Angeles, CA, USA), University Hospital Essen (Germany), and 37 other institutions randomly assigned 196 eligible patients with stroke who were receiving or had received intravenous tissue plasminogen activator (t-PA) to continue with t-PA alone (control group, 98 patients) or to undergo endovascular thrombectomy with a stent retriever within six hours after symptom onset (intervention group, 96 patients). The primary outcome was the severity of global disability at 90 days on the modified Rankin scale.
The study, which was stopped early due to efficacy, showed that in the intervention group the rate of substantial reperfusion at the end of the procedure was 88%, compared to 25%–30% in the control group. Thrombectomy with the stent retriever plus intravenous t-PA also reduced disability at 90 days over the entire range of scores on the modified Rankin scale. Functional independence was higher in the intervention group (60%) than in the control group (35%). There were no significant differences in mortality or symptomatic intracranial hemorrhage. The study was published on April 17, 2015, in the New England Journal of Medicine (NEJM).
“We are very happy to see this decade-long research program result in an important advance for stroke patients. These findings are a paradigm shift — a new era in stroke care — and we are ecstatic,” said global lead author Prof. Jeffrey Saver, MD, director of the UCLA Stroke Center. “We will be able to treat many more patients, who will have much better outcomes. This is a once-in-a-generation advance in acute stroke care.”
“While this won’t help all stroke patients, the ones it will help have the most disabling strokes,” said study coauthor Sidney Starkman, MD, co-director of the UCLA Stroke Center. “Right now, they get t-PA and it helps a third of them, but the other two-thirds end up dependent on others for help or they die.”
For the study, the researchers used the Covidien (Dublin, Ireland) Solitaire FR revascularization device, a mechanical catheter-based thrombectomy system that combines the ability to restore blood flow, administer medical therapy, and retrieve clot in patients experiencing acute ischemic stroke.
Related Links:
UCLA Stroke Center
University Hospital Essen
Covidien
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Surgical Techniques News
- AR Surgical Technology Translates Complex 2D Medical Imaging to Enhance Accuracy
- Miniaturized Snake-Like Probe Images Cerebral Arteries From Within
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors